Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Luc Teillaud

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Medecine Sciences : M/S|February 7, 2016
[The man who blew-up the lock of the anti-tumor adaptive immune response]Jean-Luc Teillaud
Medecine Sciences : M/S|September 6, 2015
[When antibodies meet anti-tumor immunity: end of the game for tumor cells?]Jean-Luc Teillaud
Medecine Sciences : M/S|December 13, 2021
Jean-Luc Teillaud
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
From whole monoclonal antibodies to single domain antibodies: think smallJean-Luc Teillaud
Medecine Sciences : M/S|February 5, 2020
[médecine/sciences listening to research]Jean-Luc Teillaud
Medecine Sciences : M/S|November 19, 2025
[Protect always and everywhere scientific research against obscurantism]Jean-Luc Teillaud
Medecine Sciences : M/S|February 1, 2012
[Mix-up of Fc receptors in the response to monoclonal antibodies]Jean-Luc Teillaud
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2004
Dossier: auto-immunity and biotherapyJean-Luc Teillaud
Expert Opinion on Biological Therapy|September 29, 2005
Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challengesJean-Luc Teillaud
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies: An old story with a bright future… with CAR-T cells!]Clémence Riffard, Jean-Luc Teillaud
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Medecine Sciences : M/S|February 7, 2016
[The man who blew-up the lock of the anti-tumor adaptive immune response]Jean-Luc Teillaud
Medecine Sciences : M/S|September 6, 2015
[When antibodies meet anti-tumor immunity: end of the game for tumor cells?]Jean-Luc Teillaud
Medecine Sciences : M/S|December 13, 2021
Jean-Luc Teillaud
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
From whole monoclonal antibodies to single domain antibodies: think smallJean-Luc Teillaud
Medecine Sciences : M/S|February 5, 2020
[médecine/sciences listening to research]Jean-Luc Teillaud
Medecine Sciences : M/S|November 19, 2025
[Protect always and everywhere scientific research against obscurantism]Jean-Luc Teillaud
Medecine Sciences : M/S|February 1, 2012
[Mix-up of Fc receptors in the response to monoclonal antibodies]Jean-Luc Teillaud
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2004
Dossier: auto-immunity and biotherapyJean-Luc Teillaud
Expert Opinion on Biological Therapy|September 29, 2005
Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challengesJean-Luc Teillaud
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies: An old story with a bright future… with CAR-T cells!]Clémence Riffard, Jean-Luc Teillaud
Pageof 10